The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

DLA Piper LLP (US)

200 SOUTH BISCAYNE BOULEVARD, SUITE 2300, MIAMI, FL 33131-5341, USA
Tel:
Work +1 305 423 8500
Fax:
Fax +1 305 437 8131
Email:
Web:
www.dlapiper.com

Joshua Kaye

Tel:
Work +1 305 423 8521
Email:
DLA Piper LLP (US)

Work Department

Healthcare

Position

Partner, Managing Partner DLA Piper's Miami Office, and Chair of DLA Piper's US Healthcare Sector

Career

Joshua Kaye concentrates his practice in healthcare mergers and acquisitions and the development of innovative business models within the healthcare industry.

Joshua advises clients in all aspects of federal and state healthcare regulatory matters, including anti-kickback, self referral laws, state licensure, Corporate Practice of Medicine and Dentistry, Certificate of Need, insurance laws and HIPAA

Education

JD, University of Miami School of Law; BA, University of Florida


United States: Industry focus

Healthcare: service providers

Within: Healthcare: service providers

DLA Piper LLP (US)’s expertise spans private equity issues, transactional work, litigation, regulatory and compliance matters, and data privacy advice. It recently advised Mednax on its £132m acquisition of Radiology Associates of South Florida; assisted DentaQuest and its subsidiary Advantage Community Company with its acquisition of the Access Dental platform in Oregon and Washington; and handled JW Childs Associates’ acquisition of Ascent Medical Group. Miami-based practice head Joshua Kaye led the work. Health data expert Anna Spencer joined the firm’s Atlanta office from Sidley Austin LLP and Adam Rogers joined Jones Day.

[back to top]

United States: M&A/corporate and commercial

Private equity buyouts

Within: Private equity buyouts

DLA Piper LLP (US) operates primarily in the middle market, with a high volume of transactions driven by the likes of ABRY Partners, Wind Point Partners, Arbor Investments, Prairie Capital, Sterling Partners and Stonebridge Partners. The firm has made a particular impression in the healthcare sector, marrying its strong private equity credentials with excellent healthcare regulatory expertise. Food and beverages, life sciences, chemicals and industrials are also key sectors. Moreover, the firm has made an impression in cross-border and multi-jurisdictional transactions for clients such as Wind Point and ABRY. It advised Wind Point on the sale of Novolex to Carlyle and represented Arbor in its acquisition of Greco & Sons. New York-based Daniel Eisner is an experienced figure, noted for his relationship with Arsenal Capital, and Atlanta’s Joe Alexander is the key relationship partner for ABRY. Miami partner Joshua Kaye is recommended for healthcare sector deals and is praised for his M&A and regulatory knowledge.

[back to top]


Back to index

Legal Developments by:
DLA Piper LLP (US)

  • Sentencing guidelines for corporate manslaughter

    In February 2010 the Sentencing Guidelines Council (the SGC) issued definitive guidelines to courts on imposing appropriate sentences for corporate manslaughter and health and safety offences causing death. The SGC states that fines imposed on companies found guilty of corporate manslaughter should not fall below £500,000, while fines in respect of health and safety offences that are a significant cause of death should be at least £100,000. Crucially, the SGC declined to provide for a fixed link between the imposed fine and the turnover or profitability of the offending company.

    - DLA Piper UK LLP

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to